Search clinical trials for: Annual versus Semiannual Albendazole plus Ivermectin MDA

Total 11 results

Washington University School of Medicine

Completed

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)

Lymphatic Filariasis | Onchocerciasis | Soil Transmitted Helminth (STH) Infections

Côte D'Ivoire
Washington University School of Medicine

Completed

Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (DOLF-LIBERIA)

Lymphatic Filariasis | Onchocerciasis | Soil Transmitted Helminth (STH) Infections

Liberia
Washington University School of Medicine

Completed

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis (DOLF-Indo)

Lymphatic Filariasis | Soil Transmitted Helminth Infections

Indonesia
London School of Hygiene and Tropical Medicine
Emory University

Terminated

Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi (FED)

Lymphatic Filariasis

Malawi
Washington University School of Medicine
National Public Health Institute of Liberia

Enrolling by invitation

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Onchocerciasis | Onchocerciasis, Ocular | Tropical Disease | Onchocercal Subcutaneous Nodule | Onchocerca Infection

Liberia
University Hospitals Cleveland Medical Center
Washington University School of Medicine

Completed

Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)

Wuchereria Bancrofti Infection

Côte D'Ivoire
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital of Nanchang University; Chinese PLA General Hospital and other collaborators

Recruiting

HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Aortic Stenosis | Aortic Stenosis With Bicuspid Valve

China
Lihir Medical Centre

Completed

PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

Trauma | Lymphatic Filariasis | Yaws

Papua New Guinea
Cardiff University
Cancer Research UK

Unknown

Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations (AML18)

Myelodysplastic Syndrome | Acute Myeloid Leukaemia

Denmark, United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

Extensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Recurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

United States

Search clinical trials for: Annual versus Semiannual Albendazole plus Ivermectin MDA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations